A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid Leukemia
NCT06762132
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
BIOLOGICAL:
CD33 CAR T-cells
Sponsor
Zhejiang University
Collaborators
[object Object]